Investors are ignoring the danger of inflation
US inflation is at its highest in almost 13 years, and UK CPI is rising at its fastest since August 2008. But stockmarkets have shrugged the figures off and bond investors are relaxed.

US inflation has hit the highest rate in almost 13 years. The consumer price index rose by 5% year-on-year in May, the fastest increase since August 2008. Core inflation, which strips out volatile food and energy costs, rose by an annual 3.8%, the measure’s biggest jump since June 1992. This week we also learnt that UK consumer prices rose at an annual pace of 2.1% last month, up from 1.5% in April.
Bonds investors are relaxed
Stockmarkets shrugged off the news, says Rupert Thompson of Kingswood. Global equities are now up by 13% so far this year. This is the second month in a row that US inflation has come in higher than forecast. You would expect bond yields, which move inversely to prices, to have risen (investors demand higher returns to compensate for higher inflation), yet they actually declined.
“What on earth is going on in the bond markets?”, asks Philip Aldrick in The Times. During the first quarter of the year, talk of inflation sent the US ten-year Treasury yield up from 0.95% up to 1.75%. Yet now it has slid back to 1.5% despite the inflation surge. Investors are being persuaded by the US Federal Reserve’s argument that the inflation spike is transitory.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Supporters of the Fed’s view point out that the inflation spike has been concentrated in a few stressed areas, says James Mackintosh in The Wall Street Journal. “Used cars and trucks alone accounted for a third of May’s monthly inflation”. Such reopening bottlenecks can be expected to ease as things get back to normal.
The Fed was proven right in 2011, when a similar spike did indeed turn out to be transitory. For all that, the fact that bond yields are falling is undeniably “bizarre”. Investors have put a lot of faith in the Fed, “leaving little room for it to be wrong”.
Commodities surge
Post-financial crisis, quantitative easing (QE), or money printing, didn’t cause a spike because it was used to patch up the then-shaky financial system, says Liam Halligan in The Daily Telegraph. But this time support has been poured straight into the real economy, with money sent “directly into the bank accounts of households and firms via government furlough and business support schemes”. The Federal Reserve added $3trn of QE to its balance sheet last year; the Bank of England’s QE pile has more than doubled since the first lockdown. Oil prices are up by 80% over the past year. Global wholesale crop prices spiked by “an extraordinary 40% in May”, further evidence of inflation.
Statistical effects mean that US inflation may have peaked, says James Knightley for ING. But the Fed is wrong to say it will quickly return to the 2% target. Higher commodity prices, soaring consumer demand and labour shortages will keep prices buoyant. High prices in the US property market have also yet to feed through into rents. US inflation looks set to stay above 4% until early next year. Policymakers’ insistence that monetary policy can be left ultra-loose for years to come is looking increasingly silly. The Fed’s Jackson Hole conference, scheduled for August, “could be very interesting”.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine
-
Pensions revolution: how to profit from the trends shaping the UK pension system
The UK pension system is one of the biggest in the world. Big changes are under way, says Rupert Hargreaves
By Rupert Hargreaves